Association of calcium channel blocker use with lower hemoglobin levels in chronic kidney disease

CIKRIKCIOGLU, M.; Karatoprak, CUMALİ; Cakirca, MUSTAFA; Kiskac, MUHARREM; Zorlu, MEHMET; Cetin, GÜVEN; YILDIZ, KEMALETTİN; ERKOC, R.; ALAY, M.; Erkal, S.; Erkal, S.; DOGAN, S.; Kazancioglu, Rümeyza

Association of calcium channel blocker use with lower hemoglobin levels in chronic kidney disease

Atıf İçin Kopyala

CIKRIKCIOGLU M. A. , Karatoprak C. , Cakirca M. , Kiskac M. , Zorlu M. , Cetin G. , et al.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, cilt.17, ss.2530-2537, 2013 (SCI İndekslerine Giren Dergi)

Cilt numarası: 17 Konu: 18
Basım Tarihi: 2013
Dergi Adı: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
Sayfa Sayısı: ss.2530-2537

Özet

AIM: To search whether calcium channel blockers (CCBs) are associated with lower hemoglobin levels in chronic kidney disease (CKD) patients who are not on renal replacement therapy (RRT), vitamin D and anti-anemic treatment.